Videos

A stack deep silicon photon counting CT detector components. The University of Wisconsin is working with GE Healthcare to develop the new PCD technology. The system and the deep silicon technology was unveiled at RSNA 2022. #RSNA22 #PCCT

VIDEO: Photon-counting CT development at the University of Wisconsin

Tim Szczykutowicz, PhD, DABR, associate professor of radiology at the University of Wisconsin-Madison, is helping develop a new type of photon-counting CT detector that was shown as a work-in-progress by GE Healthcare at RSNA 2022.

Example of AI automated detection and highlighting of critical lung findings on a chest X-ray for a possible lung cancer nodule and fibrosis. Example shown by AI vendor Lunit.

VIDEO: Radiology AI trends at RSNA 2022

Sanjay Parekh, PhD, senior market analyst with Signify Research, discusses trends in radiology AI seen on the expo floor and in sessions at RSNA 2022.

VIDEO: Impact of the 2023 Medicare cuts on radiology

Ed Gaines, JD, vice president of regulatory affairs and industry liaison, Zotec Partners, discussed the impact of the 2023 Medicare Fee Schedule on radiology at RSNA 2022 in Chicago last week. RSNA and several other medical societies say the cuts are not sustainable.

Ed Gaines, JD, CCP, vice president of regulatory affairs and industry liaison, Zotec Partners, discusses the No Surprises Act on radiology at the Radiological Society of North America (RSNA) 2022 meeting. Gaines works with RSNA on billing and Medicare issues and spoke in sessions at the RSNA 2022 meeting. Insurance companies have weaponized the No Surprises Act in an effort to cut their costs, he said.

VIDEO: Insurance companies have weaponized the No Surprises Act, may impact patient care

Ed Gaines, JD, CCP, vice president of regulatory affairs and industry liaison, Zotec Partners, discusses the impact of the No Surprises Act on healthcare and medical imaging at the RSNA 2022 meeting

Jorge Soto, MD, chair of the RSNA Annual Meeting Program Planning Committee, chief of radiology, Boston Medical Center, and professor of medicine, Boston University School of Medicine, offers an overview of the trends, hot topics, and innovative research and technology at the Radiological Society of North America (RSNA) 2022 meeting.

VIDEO: Key takeaways from RSNA 2022

Jorge Soto, MD, chair of the RSNA Annual Meeting Program Planning Committee, chief of radiology, Boston Medical Center, offers an overview of the trends, hot topics, research and technology at the Radiological Society of North America (RSNA) 2022 meeting.

Bruce Haffty, MD, president of Radiological Society of North America (RSNA) Board of Directors, chair of radiation oncology, associate vice chancellor for cancer programs at Rutgers Cancer Institute of New Jersey and system director of radiation oncology at RWJBarnabas Health, discusses the president’s address "Diagnostic Imaging: Value From the Lens of the Patient," with Radiology Business. Haffty will present his opening session at RSNA 2022 at 4 p.m., Nov. 27, 2022, in the Arie Crown theater.  

VIDEO: RSNA President Bruce Haffty previews the big conference in Chicago

Haffty offered his perspective on the conference as a whole and previewed his presidential address, which is scheduled for early Sunday evening.

Brian Lindman, MD, MSCI, medical director of the Structural Heart and Valve Center and an associate professor of medicine, Vanderbilt University Medical Center, explains the new American Heart Association (AHA) Target Aortic Stenosis (AS) program. It was announced at the AHA 2022 meeting and is designed to help screen with echo to find more AS patients.

VIDEO: AHA says aortic stenosis is undertreated and underdiagnosed

Brian Lindman, MD, medical director of the Structural Heart and Valve Center, Vanderbilt University Medical Center, explains the new American Heart Association (AHA) Target Aortic Stenosis (AS) program to screen with echo to find more AS patients. 

James Udelson, MD, from Tufts and an investiogator in the PRECISE trial, explains how FFR-CT combined with coronary CT outperformed the standard of care in patients with stable chest pain, or low-risk patients with suspected coronary involvement.

VIDEO: PRECISE trial shows cardiac CT with FFR-CT significantly improves patient outcomes

James Udelson, MD, an investigator involved with the PRECISE trial, explained how patient outcomes were improved by 70% from the current standard of care.

Around the web

CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.